Liu X - Search Results

1

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.

Liu X, Tang H, Chen J, Song C, Yang L, Liu P, Wang N, Xie X, Lin X, Xie X. Liu X, et al. Among authors: liu p. Oncotarget. 2015 Aug 21;6(24):20070-83. doi: 10.18632/oncotarget.4039. Oncotarget. 2015. PMID: 26036638 Free PMC article.

2

Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Lin X, Wu M, Liu P, Wei F, Li L, Tang H, Xie X, Liu X, Yang L, Xie X. Lin X, et al. Among authors: liu x, liu p. Med Oncol. 2014 Apr;31(4):868. doi: 10.1007/s12032-014-0868-9. Epub 2014 Feb 22. Med Oncol. 2014. PMID: 24563327

3

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.

Chen B, Tang H, Liu X, Liu P, Yang L, Xie X, Ye F, Song C, Xie X, Wei W. Chen B, et al. Among authors: liu x, liu p. Cancer Lett. 2015 Jan 28;356(2 Pt B):410-7. doi: 10.1016/j.canlet.2014.09.028. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304371

4

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Tang H, Liu P, Yang L, Xie X, Ye F, Wu M, Liu X, Chen B, Zhang L, Xie X. Tang H, et al. Among authors: liu x, liu p. Mol Cancer Ther. 2014 Dec;13(12):3185-97. doi: 10.1158/1535-7163.MCT-14-0243. Epub 2014 Oct 15. Mol Cancer Ther. 2014. PMID: 25319390

5

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

Liu P, Tang H, Chen B, He Z, Deng M, Wu M, Liu X, Yang L, Ye F, Xie X. Liu P, et al. Among authors: liu x. Cancer Lett. 2015 Feb 1;357(1):384-392. doi: 10.1016/j.canlet.2014.11.050. Epub 2014 Nov 27. Cancer Lett. 2015. PMID: 25434799

6

MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.

Liu X, Lei Q, Yu Z, Xu G, Tang H, Wang W, Wang Z, Li G, Wu M. Liu X, et al. Oncotarget. 2015 Apr 10;6(10):7930-43. doi: 10.18632/oncotarget.3181. Oncotarget. 2015. PMID: 25829251 Free PMC article.

7

LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.

Yang L, Tang H, Kong Y, Xie X, Chen J, Song C, Liu X, Ye F, Li N, Wang N, Xie X. Yang L, et al. Among authors: liu x. Stem Cells. 2015 Oct;33(10):2913-24. doi: 10.1002/stem.2083. Epub 2015 Jul 14. Stem Cells. 2015. PMID: 26086949

8

miR-200c inhibits breast cancer proliferation by targeting KRAS.

Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye F, Xie X, Chen J, Tang H, Xie X. Song C, et al. Among authors: liu x, liu lz. Oncotarget. 2015 Oct 27;6(33):34968-78. doi: 10.18632/oncotarget.5198. Oncotarget. 2015. PMID: 26392416 Free PMC article.

9

miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.

Ye F, Tang H, Liu Q, Xie X, Wu M, Liu X, Chen B, Xie X. Ye F, et al. Among authors: liu x, liu q. J Transl Med. 2014 Jan 21;12:17. doi: 10.1186/1479-5876-12-17. J Transl Med. 2014. PMID: 24447584 Free PMC article.

10

Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a.

Xiao X, Chen B, Liu X, Liu P, Zheng G, Ye F, Tang H, Xie X. Xiao X, et al. Among authors: liu x, liu p. PLoS One. 2014 Nov 14;9(11):e112720. doi: 10.1371/journal.pone.0112720. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2023 Dec 12;18(12):e0295991. doi: 10.1371/journal.pone.0295991 PMID: 25396727 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,109 results

Search Page

Filters